Search Results for agency_names:"Substance Abuse and Mental Health Services Administration"

The Substance Abuse and Mental Health Services Administration (SAMHSA) is seeking approval for its evaluation of the Certified Community Behavioral Health Clinic Expansion (CCBHC-E) Grant Program, which started in FY 2022. This program supports both new and existing clinics to improve behavioral health care access, coordination, and quality. SAMHSA plans to use various data collection methods, including surveys, interviews, and focus groups with grantees, clinic staff, clients, and related organizations, to assess the program’s impact and implementation. Inputs from these activities will help SAMHSA understand the program's effectiveness and opportunities for improvement.

The Substance Abuse and Mental Health Services Administration (SAMHSA), part of the Department of Health and Human Services, announced additional funding for five grant recipients from the FY 2020 National Consumer and Consumer Supporter Technical Assistance Centers initiative. The extra funding totals $1,806,000, allowing each recipient to receive up to $361,200. This funding will extend their projects by 12 months, until March 30, 2026, enabling them to continue supporting mental health services for adults with serious mental illness. These funds are only available to the original grant recipients who demonstrate satisfactory applications and budgets.

The Substance Abuse and Mental Health Services Administration (SAMHSA), in line with the Paperwork Reduction Act of 1995, invites public comments on its plan to collect data for evaluating the 988 Suicide & Crisis Lifeline and Crisis Services Program. This evaluation aims to improve the quality and effectiveness of crisis care by analyzing the implementation, outcomes, and impact of the 988 Lifeline, which connects people in crisis to essential support services across the U.S. The evaluation consists of system-level, client-level, and impact studies, involving various SAMHSA-funded and related programs. SAMHSA encourages written feedback on the necessity and efficiency of the proposed data collection by January 31, 2025.

The Substance Abuse and Mental Health Services Administration's National Advisory Council (SAMHSA NAC) will hold a public virtual meeting on March 22, 2021, from 1:00 p.m. to 5:00 p.m. (ET). The meeting will cover updates on SAMHSA priorities, new grants, and initiatives, as well as a discussion on national issues in mental health and substance use. Interested persons can submit their views in writing or orally, with written submissions due seven days before the meeting. Details for attending the meeting and submitting comments are available on the SAMHSA website.

The Substance Abuse and Mental Health Services Administration (SAMHSA) is proposing a new tool called the SAMHSA Unified Client-Level Performance Reporting Tool (SUPRT) to streamline and improve how they collect data on mental health and substance use programs. This tool aims to reduce the burden on clients by allowing self-administered questionnaires and using administrative data from grantees. The SUPRT will help SAMHSA align its data collection with other federal agencies and improve its ability to monitor and evaluate the performance of its grant programs, contributing to broader public health goals. Public comments on this proposal can be submitted to the Office of Management and Budget by January 6, 2025.

The Substance Abuse and Mental Health Services Administration (SAMHSA) is extending the approval of the current format for the annual Synar report, which monitors state compliance with laws prohibiting the sale of tobacco to those under 21. As part of the Block Grant funding requirements, states must enforce these laws, perform random inspections, and submit reports on their progress in reducing youth access to tobacco. Non-compliance may result in penalties or require states to undertake corrective action. Public comments on this information collection can be submitted within 30 days of this notice's publication.

The Department of Health and Human Services (HHS) has released a notice which informs federal agencies about the laboratories and facilities certified to conduct drug testing using urine and oral fluid as per the Mandatory Guidelines for Federal Workplace Drug Testing Programs. As of now, there are no labs certified for oral fluid testing, but several are certified for urine testing, including those in Canada, which are overseen by the standards of the Department of Transportation (DOT). The list includes details about each certified laboratory and highlights a facility that is withdrawing from the certification program.

The Department of Health and Human Services (HHS) has released a notice listing laboratories and Instrumented Initial Testing Facilities (IITFs) certified for drug testing federal employees, as per the Mandatory Guidelines. These guidelines cover tests using urine and oral fluids, though currently, no labs are certified for oral fluid testing. Laboratories must meet strict standards and undergo regular inspections to stay certified. The notice includes a detailed list of certified facilities approved to test urine samples, ensuring they meet the necessary criteria for thorough and accurate testing.

The Department of Health and Human Services (HHS) releases a notice informing federal agencies about laboratories and Instrumented Initial Testing Facilities (IITFs) certified to handle urine and oral fluid drug testing. The notice outlines that the certified labs meet the standards required for federal workplace drug testing. No laboratories are currently approved to conduct drug testing on oral fluid samples. The document lists various laboratories that are certified to perform drug tests on urine samples and describes the certification process for these testing facilities.

The Substance Abuse and Mental Health Services Administration (SAMHSA) is announcing an upcoming meeting of the Center for Substance Abuse Treatment's National Advisory Council (NAC) on March 31, 2021. The meeting will be held virtually and is open to the public. Topics to be discussed include updates on CSAT activities, the use of technology in substance use disorder treatment, and issues facing rural and frontier communities. Interested individuals are invited to register to participate and can make oral or written presentations if they notify the designated contact person by March 19, 2021.